Genomic and proteomic studies have a profound impact on public health by enabling rapid identification and characterization of pathogens, which is crucial for outbreak response. They also aid in the development of targeted therapies and vaccines, improving disease management and control. Furthermore, these studies can help in the surveillance of antibiotic resistance, guiding the use of antimicrobial agents and informing public health policies.
